Johnson & Johnson Talc Settlement | Canada News

Johnson & Johnson faces a $5.5 billion settlement to resolve thousands of lawsuits alleging its talc products caused ovarian cancer — a battle it’s fought for over a decade, calling the evidence “junk science.” After rejecting a prior $9 billion offer, the company now accepts terms that require 95% of remaining 76,000 claimants to agree, with payments starting next year and the rest deferred until 2028. Despite confident courtroom hopes, executives see this as a way to finally move on and refocus on life-saving innovation. Meanwhile, science remains divided — some studies hint at risk, others find none — while the WHO classifies talc as “possibly carcinogenic” based on limited evidence. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ec9bd485fc965432